The effect of CoQ10 supplementation on some complications of type 2 diabetes

Phase 3

• Conditions: Type II Diabetes.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT201109127541N1
• Lead Sponsor: Shahid Sadoughi University of Medical Sciences and Health Services

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 70

Inclusion Criteria

1.The agreement of the patients to contribute in the trial; 2. patients that have type two diabetes for at least 5 years; 3.The patients should have neuropathy symptoms that have been recognized by a physician (The patients’ score on the Michigan score should be at least 8 and their nerve reflexes should be weak); 4.The patients should not have any other neurologic, kidney or hepatic diseases; 5.If the patients take medicine for neuropathy, the dosage of their medicine should not change during the trial; 6.If the patients have not taken a medicine at the beginning of the trial, they should not start taking it during the trial; 7.The patients should not have taken antioxidant supplements from the past 3 months. Exclusion criteria 1.If a dosage of a patient's medicine changes that patient will be excluded from the trial; 2.If a patient who has not taken any medicine for his neuropathy starts to take a medicine during the trial that patient will be excluded from the trial; 3.Pregnancy and lactation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified